1) Intestinal Mucosal Barrier/drug eff
肠黏膜屏障/药物作用
2) Intestinal Mucosal Barrier
肠黏膜屏障
1.
Intestinal mucosal barrier and inflammatory bowel disease;
肠黏膜屏障与炎症性肠病
2.
Protective effect of Sijunzi decoction plus rhubarb on intestinal mucosal barrier of septic rats;
四君子汤加大黄对脓毒症大鼠肠黏膜屏障功能的保护作用
3.
Influence of somatostatin on GH-IGF-1-albumin axis of necrotizing pancreatitis and the protective effect on the intestinal mucosal barrier of rats;
生长抑素对大鼠坏死性胰腺炎GH-IGF-1-白蛋白轴的影响及其对肠黏膜屏障的保护作用
3) Intestinal Mucosa Barrier
肠黏膜屏障
1.
Influence of early enteral nutrition on the function of intestinal mucosa barrier in patient with severe acute pancreatitis;
早期肠内营养对重症急性胰腺炎患者肠黏膜屏障功能的影响
2.
Dynamic changes of intestinal mucosa barrier by partial hepatectomy in rats;
肝大部切除大鼠肠黏膜屏障的动态变化
3.
Influence of CO_2 pneumoperitoneum on intestinal mucosa barrier in cirrhotic rats;
气腹对肝硬化大鼠肠黏膜屏障功能的影响
4) gut mucosal barrier
肠黏膜屏障
1.
Effect of total hepatic inflow occlusion on gut mucosal barrier;
肝门阻断对肠黏膜屏障的影响
2.
An experimental study on the gut mucosal barrier dysfunction in rats with acute necrotizing pancreatitis;
大鼠急性坏死性胰腺炎肠黏膜屏障功能障碍的观察
5) gut barrier
肠黏膜屏障
1.
OBJECTIVE By setting up AP model in SD rats,we observe the process ofsevere acute pancreatitis associated gut barrier dysfunction, and investigate the role of secrum TNF-a、IL-6、LPS、 ICAM-1 and pathology changes of pancreas and intestinalMETHODS Rats of SAP were induced by retrograde injection of 5% sodiumtaurocholate into the pancreatic duct.
目的 本文旨在通过建立大鼠重症急性胰腺炎(severe acute pancreatitis，SAP)模型，检测内毒素(LPS)、肿瘤坏死因子α(TNF-α)、白细胞介素6(IL-6)水平以及肠黏膜细胞黏附分子(ICAM-1)的表达，并观察胰腺、小肠病理形态的改变，探讨SAP时肠黏膜屏障变化的机理，尤其是炎症介质与细胞黏附分子在重症急性胰腺炎肠道黏膜屏障功能障碍中的相关性。
2.
Gut barrier dysfunction could result in bacterial translocation,endotoxemia and secondary infection of pancreatitis,which cause "second attack" to the body.
重症急性胰腺炎时常并发肠黏膜屏障功能障碍,导致肠道细菌移位,内毒素血症,胰腺继发感染,造成对机体的"二次打击"。
3.
Objective To investigate the process of severe acute pancreatitis associated gut barrier dysfunction,and to explore the early diagnosis basis of gut barrier dysfunction.
目的探讨重症急性胰腺炎(SAP)时肠黏膜屏障变化的机制,寻求其并发肠道黏膜屏障功能障碍早期诊断依据。
6) Intestinal barrier
肠黏膜屏障
1.
Decrease of intestinal barrier after ischemia-reperfusion injury in animals;
缺血再灌注损伤降低肠黏膜屏障功能的初步研究
2.
Change of intestinal barrier after fasting in animals: Observations of morphology and bacteria translocation;
禁食降低肠黏膜屏障的形态学观察及对肠道细菌易位的影响
3.
Liver disease can lead to the dysfunction of intestinal barrier and thus cause the bacterial translocation, which may result in bacteremia and endotoxemia and,in return,exaggarate the liver injury.
肝脏疾病可以引起肠黏膜屏障受损,进而肠道内细菌发生移位,导致菌血症和内毒素血症,并进一步加重肝损伤。
补充资料：膜屏障作用
膜屏障作用
细胞外Ca++在心肌细胞膜上对Na+的内流有竞争性抑制作用。由此可见，细胞外ca++浓度发生变化时，与ca++内流和 Na+内流有关的生物电活动都将受到影响，而对静息电位则无明显作用。细胞外Ca++浓度增高时，对Na+内流的膜屏障作用加大，Na+内流过程普遍受抑制。细胞外Ca++浓度降低对心肌生理特性的影响，与高Ca++浓度的影响基本上是相反的。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条